Jun 20,2022 | Healthcare Services
An Autoinjector is a type of medical device intended to provide a dose of a specific drug. It has a syringe-like structure with a spring-charged needle allowing a pre-charged dosage of the drugs. The device is extensively utilized for epinephrine self-administration (to inhibit the prevalence of anaphylaxis); by migraine patients (for instant pain relief); or in an emergency and medical treatments. Auto-injectors are increasingly preferred over traditional devices since they facilitate advanced and effective drug delivery as well as new formulations.
Further, they are often used to provide a variety of benefits, such as reducing needle-associated phobia syndrome, lowering hazards of needle stuck mishaps, ensuring dosage quality stability and also helps to increase effectiveness, thereby accelerating the market growth worldwide. Moreover, the rise in prevalence of multiple sclerosis and anaphylaxis, favourable reimbursements and government support, and the high availability of generic versions of autoinjectors are the few factors responsible for the CAGR of the market during the forecast period.
Under the medical device market research reports, Bharatbook offers the latest study that examines the current market and projected market potential for autoinjectors. It offers a detailed analysis of the competitive environment, market background, technology, drivers and restraints, and market growth trends. The Autoinjectors market report also includes market projections to 2026 and rankings for key market players. The report segments the market for autoinjectors based on the type of product, route of administration, therapy, end user and geography or region.
The report is designed to incorporate both qualitative and quantitative aspects of the medical device industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
North America is the leading region across the world in terms of market share owing to the government support and rising demand for high-quality medical products, along with the presence of a significant number of market vendors in the region. Also, factors such as the rise in incidences of autoimmune and chronic diseases coupled with the improving healthcare infrastructure in developing countries, such as China and India, would create lucrative growth prospects for the Autoinjectors market across the Asia-Pacific region.
Company profile descriptions of the leading manufacturers and suppliers of autoinjector devices including AbbVie Inc., Amgen Inc., Becton, Dickinson and Co., Eli Lilly, GlaxoSmithKline PLC, Johnson & Johnson, Merck KGaA and Teva Pharmaceutical.
To know more the specific medical device market, please visit Autoinjectors: Global Markets.